Helena Linardou: Honored to be nominated for IASLC Board of Directors, Seat #1
Helena Linardou, Director of the 4th Oncology Department and the Comprehensive Clinical Trials Center of Metropolitan Hospital in Athens, shared a post on X:
“Dear thoracic oncology friends, IASLC members, the Board of Directors election is on!!
Let’s support as many of the amazing candidates!
I’m honored to share that I’ve been nominated for the IASLC Board of Directors elections for Undesignated Seat #1.
It’s a privilege to be considered among such an inspiring group of candidates, all deeply committed to advancing thoracic oncology worldwide.
I’m passionate about continuing to contribute to our global community, and I’d truly appreciate your support and your vote.
Thank you to all who make IASLC such a vital and collaborative organization!”
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington, shared a post on X by Helena Linardou, adding:
“Good luck Helena Linardou and to all the candidates.”
Stay updated on IASLC Board Elections on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023